share_log

VYNE Therapeutics | 10-K: FY2024 Annual Report

SEC ·  Mar 6 21:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 376

Recommended